Prestige Clinic Rsrch Ctr — research payments reported

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$346,903	31
2024	Research	$671,578	46
2023	Research	$2,603,946	33
2022	Research	$4,226,395	72

Breakdown

Who paid Research payments · program years 2022–2025

Janssen Pharmaceuticals, Inc $4,935,048 65 payments
Janssen Research & Development, LLC $2,913,774 117 payments

Studies the money was for Research payments · program years 2022–2025

A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older $4,935,048 65 payments
A Study of Ad26.COV2.S for the Prevention of SARSCoV2mediated COVID19 in Adults $1,504,209 34 payments
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years $1,409,565 83 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.